ABCC3 and cancer: The ABCC3 (canalicular multispecific organic anion transporter 2) gene, the 3′ partner in the MED1 (mediator complex subunit 1)-ABCC3 fusion, is known to efflux therapeutic compounds resulting in multidrug resistance in cancer cells [54, 55].